← Back to headlines
China Adds Second GLP-1 Diabetes Drug to Essential Medicine List
China has expanded its essential medicine list by including a second GLP-1 diabetes drug. This move aims to improve access and affordability for patients managing diabetes across the country.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
